Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000041

Director sold 20,000 shares at $25.37 ($507,400)

  • Director acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schenkein David P · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-27 Exercise or conversion : show line 1 in the form +20,000 $9.05 $181,000 137,879 D
2023-02-27 Sale : show line 2 in the form −20,000 $25.37 $507,400 117,879 D
Open-market sales · 20,000 sh · avg $25.37 · $507,400

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-27 Exercise or conversion : show line 3 in the form Stock option (right to buy) −20,000 56,363 D
Loading xslF345X03/wf-form4_167770476285855.xml…